Physician profile
Mark Mettauer
NPI 1427043967
$3,112.94
in general payments reported to CMS, 2019-2025
11 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $287 · 2021: $434 · 2022: $545 · 2023: $389 · 2024: $301 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,131.64 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Elutia, INC. | $855.98 | 2019-2023 | |
| Inari Medical, INC. | $297.24 | 2021-2022 | |
| Edwards Lifesciences Corporation | $262.07 | 2019-2025 | |
| Livanova USA, INC. | $186.50 | 2021-2023 | Essenz |
| Atricure, INC. | $141.29 | 2022-2025 | Synergy Ablation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.62 | 2019 | |
| Abiomed | $60.85 | 2023-2024 | Impella |
| Baxter Healthcare | $31.52 | 2023 | Preveleak |
| Merck Sharp & Dohme LLC | $12.85 | 2019 | |
| Bolton Medical INC | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mettauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.